VC gains momentum in 1Q, starts strong in 2Q

Save

US venture capital investment in biotechnology companies totaled $1.1bn for the first quarter of 2014 – the highest January-to-March total since 2008 – and the second quarter is off to a strong start in the US and abroad for Nora…